NASDAQ:FBRX
Forte Biosciences Inc. Stock Company Profile
$0.720
+0.0059 (+0.83%)
At Close: May 06, 2024
Information
3060 Pegasus Park Drive, Building 6
Dallas TX 75247
310 618 6994
www.fortebiorx.com
Industry: Biotechnology
Sector: Healthcare
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.